LAMOTRIGINE

LAMOTRIGINE was reported 133040 times

LAMOTRIGINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOCHOLESTEROLAEMIA 114 0.3229
1 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 170 0.3178
2 LIP EROSION 227 0.3110
3 FACET JOINT SYNDROME 795 0.2439
4 ORAL MUCOSA EROSION 244 0.1984
5 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 127 0.1954
6 OVERLAP SYNDROME 132 0.1886
7 MULTIPLE-DRUG RESISTANCE 547 0.1762
8 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 82 0.1752
9 PERIPHERAL VENOUS DISEASE 674 0.1649
10 FOCAL DYSCOGNITIVE SEIZURES 184 0.1615
11 ONYCHOMADESIS 671 0.1597
12 BLEPHAROSPASM 997 0.1582
13 COMPLEX PARTIAL SEIZURES 173 0.1556
14 AURA 285 0.1527
15 ENANTHEMA 83 0.1441
16 MYOCLONIC EPILEPSY 218 0.1436
17 ATONIC SEIZURES 122 0.1420
18 ANTICONVULSANT DRUG LEVEL DECREASED 195 0.1380
19 PETIT MAL EPILEPSY 700 0.1370
20 BREAST CANCER STAGE III 873 0.1347
21 SELECTIVE EATING DISORDER 122 0.1341
22 CHANGE IN SEIZURE PRESENTATION 86 0.1329
23 SJS-TEN OVERLAP 89 0.1268
24 DEVELOPMENTAL HIP DYSPLASIA 100 0.1202
25 STEVENS-JOHNSON SYNDROME 2673 0.1201
26 RHEUMATIC FEVER 529 0.1186
27 DUODENAL ULCER PERFORATION 869 0.1167
28 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 836 0.1166
29 ANTICONVULSANT DRUG LEVEL INCREASED 185 0.1145
30 EPILEPSY 3502 0.1144
31 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 86 0.1142
32 LIVE BIRTH 934 0.1115
33 SEIZURE CLUSTER 92 0.1110
34 ONYCHOMYCOSIS 477 0.1086
35 HYPOSPADIAS 226 0.1085
36 PARTIAL SEIZURES 563 0.1074
37 PLEUROTHOTONUS 97 0.1073
38 LUPUS VULGARIS 135 0.1071
39 SIMPLE PARTIAL SEIZURES 82 0.1016
40 AGITATION NEONATAL 97 0.1011
41 TONIC CONVULSION 142 0.1001
42 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2545 0.0988
43 GENERALISED TONIC-CLONIC SEIZURE 1633 0.0986
44 RESPIRATORY DISORDER NEONATAL 158 0.0974
45 SPINA BIFIDA 203 0.0974
46 DYSMORPHISM 227 0.0963
47 BRUGADA SYNDROME 98 0.0947
48 HYPOMANIA 345 0.0937
49 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 302 0.0930
50 POLYDACTYLY 107 0.0922
51 COARCTATION OF THE AORTA 89 0.0921
52 DISLOCATION OF VERTEBRA 207 0.0907
53 MUSCLE INJURY 744 0.0897
54 TOXIC EPIDERMAL NECROLYSIS 1345 0.0885
55 STATUS EPILEPTICUS 986 0.0872
56 FEEDING DISORDER NEONATAL 91 0.0870
57 NYSTAGMUS 460 0.0866
58 FOETAL ANTICONVULSANT SYNDROME 102 0.0860
59 CLEFT LIP AND PALATE 96 0.0859
60 BIPOLAR I DISORDER 187 0.0852
61 FOLLICULITIS 890 0.0848
62 NAIL DISORDER 723 0.0826
63 HELICOBACTER INFECTION 842 0.0818
64 LIP DRY 744 0.0818
65 ATAXIA 968 0.0815
66 INFUSION SITE REACTION 241 0.0806
67 BIPOLAR DISORDER 857 0.0788
68 CLEFT PALATE 152 0.0786
69 FOETAL MALFORMATION 85 0.0782
70 MICROCEPHALY 100 0.0779
71 PEMPHIGUS 967 0.0773
72 HYPERCHOLESTEROLAEMIA 733 0.0758
73 BURSITIS 917 0.0755
74 ELECTROENCEPHALOGRAM ABNORMAL 233 0.0737
75 WOUND INFECTION 804 0.0733
76 INTELLECTUAL DISABILITY 109 0.0718
77 HYPOTONIA NEONATAL 112 0.0717
78 MANIA 1166 0.0708
79 OCULOGYRIC CRISIS 151 0.0703
80 BRADYCARDIA NEONATAL 88 0.0700
81 HAND DEFORMITY 916 0.0698
82 ATRIAL SEPTAL DEFECT 583 0.0695
83 GRAND MAL CONVULSION 642 0.0695
84 FINGER DEFORMITY 327 0.0674
85 DEEP VEIN THROMBOSIS POSTOPERATIVE 135 0.0674
86 MUCOUS MEMBRANE DISORDER 92 0.0673
87 C-REACTIVE PROTEIN ABNORMAL 428 0.0667
88 VENTRICULAR SEPTAL DEFECT 382 0.0666
89 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 333 0.0649
90 RASH MORBILLIFORM 180 0.0649
91 GAZE PALSY 110 0.0645
92 BEZOAR 89 0.0645
93 TALIPES 200 0.0643
94 CONVULSION 3674 0.0642
95 BACK INJURY 695 0.0638
96 CONGENITAL ANOMALY 490 0.0632
97 SUSPECTED SUICIDE 292 0.0622
98 PSYCHOMOTOR RETARDATION 175 0.0622
99 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 129 0.0622
100 OBESITY 989 0.0620
101 CONJUNCTIVAL HYPERAEMIA 221 0.0619
102 X-RAY ABNORMAL 110 0.0615
103 PERICARDITIS 1026 0.0610
104 PATENT DUCTUS ARTERIOSUS 241 0.0606
105 DRUG WITHDRAWAL CONVULSIONS 107 0.0601
106 STARING 145 0.0599
107 SEIZURE 6895 0.0596
108 EXCESSIVE EYE BLINKING 88 0.0595
109 RETINITIS 102 0.0590
110 GRIP STRENGTH DECREASED 515 0.0585
111 JOINT RANGE OF MOTION DECREASED 778 0.0580
112 MULTIPLE CONGENITAL ABNORMALITIES 83 0.0576
113 HYPERREFLEXIA 198 0.0568
114 OBSESSIVE THOUGHTS 100 0.0554
115 PRODUCT LABEL CONFUSION 320 0.0549
116 CLONUS 150 0.0548
117 EXPOSURE VIA BREAST MILK 218 0.0547
118 GAMBLING DISORDER 147 0.0544
119 CEREBELLAR SYNDROME 118 0.0538
120 WRONG PATIENT RECEIVED PRODUCT 156 0.0533
121 OBSESSIVE-COMPULSIVE DISORDER 427 0.0532
122 MATERNAL DRUGS AFFECTING FOETUS 407 0.0530
123 SYNOVITIS 938 0.0520
124 BRAIN OPERATION 118 0.0516
125 DRUG SCREEN FALSE POSITIVE 142 0.0513
126 ANTIPSYCHOTIC DRUG LEVEL INCREASED 143 0.0507
127 DRUG ERUPTION 900 0.0507
128 BEHAVIOUR DISORDER 273 0.0504
129 GLOSSODYNIA 1126 0.0502
130 MATERNAL EXPOSURE DURING BREAST FEEDING 204 0.0502
131 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 207 0.0498
132 TACHYPHRENIA 172 0.0496
133 DRUG LEVEL INCREASED 808 0.0488
134 COMPULSIVE SHOPPING 100 0.0486
135 CLUMSINESS 132 0.0483
136 PERSONALITY DISORDER 126 0.0481
137 SWOLLEN JOINT COUNT INCREASED 153 0.0479
138 LOGORRHOEA 168 0.0476
139 DRUG EXPOSURE DURING PREGNANCY 1607 0.0472
140 MENINGITIS ASEPTIC 211 0.0470
141 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 351 0.0467
142 NEONATAL RESPIRATORY DISTRESS SYNDROME 165 0.0466
143 MYOCLONUS 553 0.0463
144 TONGUE BITING 94 0.0455
145 HOSTILITY 115 0.0452
146 GENERALISED ERYTHEMA 256 0.0450
147 RASH MACULO-PAPULAR 977 0.0439
148 INTENTIONAL SELF-INJURY 880 0.0435
149 FOETAL EXPOSURE DURING PREGNANCY 3527 0.0433
150 IMPULSE-CONTROL DISORDER 89 0.0432
151 TASTE DISORDER 876 0.0431
152 DEPRESSIVE SYMPTOM 152 0.0431
153 LIBIDO INCREASED 87 0.0429
154 SPEECH DISORDER DEVELOPMENTAL 123 0.0428
155 SUICIDAL BEHAVIOUR 177 0.0425
156 FIBROMYALGIA 1033 0.0424
157 IRRITABLE BOWEL SYNDROME 909 0.0424
158 PSYCHOMOTOR SKILLS IMPAIRED 111 0.0423
159 DRUG TITRATION ERROR 109 0.0422
160 COELIAC DISEASE 412 0.0420
161 ERYTHEMA MULTIFORME 387 0.0415
162 NORMAL NEWBORN 223 0.0410
163 RASH VESICULAR 198 0.0409
164 PSYCHOTIC SYMPTOM 84 0.0407
165 IMPULSIVE BEHAVIOUR 151 0.0402
166 STRABISMUS 118 0.0401
167 COMPLETED SUICIDE 3318 0.0398
168 TYPE 2 DIABETES MELLITUS 1333 0.0396
169 SEROTONIN SYNDROME 755 0.0393
170 PERSECUTORY DELUSION 98 0.0393
171 SMALL FOR DATES BABY 192 0.0386
172 FLAT AFFECT 89 0.0384
173 COORDINATION ABNORMAL 535 0.0383
174 SKIN EROSION 123 0.0381
175 SUICIDE ATTEMPT 2311 0.0381
176 COMA SCALE ABNORMAL 108 0.0372
177 INTENTIONAL OVERDOSE 2371 0.0369
178 HYPERTHERMIA 282 0.0369
179 WOUND 1031 0.0368
180 EXPOSURE DURING PREGNANCY 2279 0.0366
181 NEUROLEPTIC MALIGNANT SYNDROME 432 0.0364
182 AFFECTIVE DISORDER 285 0.0362
183 POISONING DELIBERATE 342 0.0360
184 BONE EROSION 127 0.0359
185 DIPLOPIA 931 0.0358
186 LYMPHADENOPATHY 1255 0.0354
187 LIVER INJURY 863 0.0351
188 CEREBRAL ATROPHY 140 0.0351
189 DRUG LEVEL DECREASED 351 0.0345
190 AGGRESSION 1723 0.0344
191 EXPOSURE DURING BREAST FEEDING 114 0.0344
192 C-REACTIVE PROTEIN INCREASED 1249 0.0343
193 AKATHISIA 465 0.0340
194 HYPERAMMONAEMIA 170 0.0340
195 PRE-EXISTING CONDITION IMPROVED 212 0.0339
196 ENURESIS 136 0.0336
197 SEDATION 880 0.0336
198 DISSOCIATION 257 0.0335
199 PARADOXICAL DRUG REACTION 122 0.0331
200 TIC 180 0.0330
201 ANXIETY DISORDER 110 0.0329
202 CHEILITIS 178 0.0329
203 INFARCTION 223 0.0326
204 SUICIDAL IDEATION 2979 0.0325
205 TOXIC SKIN ERUPTION 327 0.0324
206 SYSTEMIC LUPUS ERYTHEMATOSUS 1136 0.0320
207 MAJOR DEPRESSION 233 0.0319
208 STUPOR 102 0.0317
209 MATERNAL EXPOSURE DURING PREGNANCY 2826 0.0317
210 ADVERSE REACTION 419 0.0316
211 HALLUCINATION, AUDITORY 501 0.0315
212 FEELING DRUNK 234 0.0315
213 GESTATIONAL DIABETES 149 0.0312
214 ALCOHOL ABUSE 83 0.0310
215 HYPERTONIA 177 0.0309
216 ABORTION INDUCED 291 0.0309
217 STILLBIRTH 149 0.0308
218 RASH GENERALISED 796 0.0307
219 ANGER 1036 0.0306
220 EYE MOVEMENT DISORDER 208 0.0303
221 AUTISM SPECTRUM DISORDER 166 0.0301
222 BLISTER 1683 0.0299
223 SELF-INJURIOUS IDEATION 125 0.0298
224 CATATONIA 156 0.0297
225 BLOOD PROLACTIN INCREASED 139 0.0294
226 LOSS OF EMPLOYMENT 89 0.0294
227 HYPOGAMMAGLOBULINAEMIA 193 0.0293
228 BRUXISM 158 0.0293
229 RESPIRATORY ACIDOSIS 115 0.0292
230 POSTURE ABNORMAL 95 0.0292
231 PSYCHOTIC DISORDER 854 0.0289
232 NIGHT SWEATS 928 0.0288
233 DRUG INTERACTION 4530 0.0285
234 HYPERNATRAEMIA 142 0.0285
235 DERMATITIS EXFOLIATIVE 142 0.0283
236 PRODUCT SUBSTITUTION ISSUE 1632 0.0283
237 PRODUCT ADMINISTRATION INTERRUPTED 221 0.0281
238 HOMICIDAL IDEATION 114 0.0281
239 LIVER FUNCTION TEST INCREASED 599 0.0279
240 SNORING 105 0.0277
241 DELUSION 428 0.0275
242 AGITATION 2023 0.0275
243 DROOLING 190 0.0275
244 HYPOTONIA 274 0.0274
245 HYPERACUSIS 102 0.0274
246 PARKINSONISM 266 0.0273
247 DRUG TOLERANCE 138 0.0273
248 COMA 1285 0.0270
249 PARANOIA 465 0.0269
250 PSYCHOMOTOR HYPERACTIVITY 446 0.0268
251 HALLUCINATIONS, MIXED 113 0.0268
252 IRRITABILITY 1603 0.0266
253 IMPAIRED HEALING 873 0.0266
254 CONTRAINDICATED PRODUCT ADMINISTERED 802 0.0265
255 PSYCHIATRIC SYMPTOM 194 0.0263
256 EXOSTOSIS 240 0.0263
257 POISONING 329 0.0262
258 THINKING ABNORMAL 484 0.0259
259 ALTERED STATE OF CONSCIOUSNESS 562 0.0259
260 TOXICITY TO VARIOUS AGENTS 4374 0.0259
261 DISTURBANCE IN ATTENTION 1395 0.0258
262 HYPERPHAGIA 103 0.0258
263 MUSCLE TWITCHING 593 0.0257
264 CONCUSSION 198 0.0255
265 ABORTION SPONTANEOUS 1024 0.0255
266 ABNORMAL BEHAVIOUR 1012 0.0255
267 DRUG SCREEN POSITIVE 201 0.0254
268 FACE OEDEMA 428 0.0254
269 DRUG-INDUCED LIVER INJURY 793 0.0252
270 SOCIAL AVOIDANT BEHAVIOUR 146 0.0252
271 BLOOD CHOLESTEROL INCREASED 1171 0.0251
272 PSORIATIC ARTHROPATHY 1014 0.0250
273 HEART DISEASE CONGENITAL 88 0.0249
274 SOMNAMBULISM 163 0.0248
275 PREMATURE LABOUR 140 0.0247
276 RHEUMATOID FACTOR POSITIVE 143 0.0247
277 ORAL DISORDER 181 0.0247
278 APATHY 360 0.0247
279 FEELING OF DESPAIR 115 0.0246
280 MYDRIASIS 314 0.0245
281 CAESAREAN SECTION 284 0.0244
282 EOSINOPHILIA 426 0.0243
283 COGNITIVE DISORDER 1125 0.0241
284 PRESCRIBED OVERDOSE 463 0.0239
285 OSTEOARTHRITIS 1013 0.0239
286 POST-TRAUMATIC STRESS DISORDER 160 0.0238
287 MOOD SWINGS 759 0.0238
288 DYSKINESIA 967 0.0238
289 SALIVARY HYPERSECRETION 238 0.0238
290 MOUTH ULCERATION 500 0.0237
291 PHARYNGOLARYNGEAL PAIN 126 0.0237
292 AFFECT LABILITY 228 0.0237
293 PRE-ECLAMPSIA 112 0.0235
294 POLYDIPSIA 93 0.0235
295 ATTENTION DEFICIT HYPERACTIVITY DISORDER 99 0.0235
296 GAIT INABILITY 785 0.0235
297 DEPRESSION 5295 0.0232
298 MATERNAL EXPOSURE TIMING UNSPECIFIED 87 0.0231
299 MUSCLE RIGIDITY 276 0.0231
300 DYSARTHRIA 864 0.0229
301 DYSPHEMIA 100 0.0228
302 MENTAL IMPAIRMENT 552 0.0227
303 SOMNOLENCE 4573 0.0227
304 DEVELOPMENTAL DELAY 204 0.0226
305 DECREASED INTEREST 133 0.0225
306 BUNDLE BRANCH BLOCK RIGHT 103 0.0224
307 SINUS TACHYCARDIA 318 0.0224
308 ODYNOPHAGIA 133 0.0223
309 CRYING 807 0.0222
310 PAPULE 156 0.0221
311 PREGNANCY 443 0.0221
312 RESTLESSNESS 807 0.0220
313 SCREAMING 139 0.0218
314 MOOD ALTERED 589 0.0216
315 ERYTHEMA OF EYELID 116 0.0214
316 DYSPHORIA 108 0.0213
317 DEPRESSED LEVEL OF CONSCIOUSNESS 843 0.0213
318 HEPATIC ENZYME INCREASED 1450 0.0212
319 HEPATITIS 544 0.0212
320 SOPOR 281 0.0212
321 ENCEPHALOPATHY 520 0.0212
322 AMNESIA 1376 0.0211
323 INFLAMMATION 1087 0.0210
324 SLEEP DISORDER 1485 0.0210
325 CONFUSIONAL STATE 3398 0.0210
326 MEMORY IMPAIRMENT 2856 0.0208
327 HALLUCINATION, VISUAL 438 0.0207
328 ELECTROCARDIOGRAM QT PROLONGED 746 0.0207
329 CONJUNCTIVITIS 384 0.0207
330 APHASIA 624 0.0206
331 PHOTOPHOBIA 388 0.0206
332 PURPURA 182 0.0205
333 PERSONALITY CHANGE 191 0.0205
334 MIGRAINE 1950 0.0204
335 LUPUS-LIKE SYNDROME 183 0.0202
336 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 207 0.0201
337 BALANCE DISORDER 1735 0.0201
338 RASH 8746 0.0200
339 BRADYPHRENIA 131 0.0200
340 APNOEA 156 0.0200
341 PERFORMANCE STATUS DECREASED 93 0.0199
342 OVERWEIGHT 107 0.0199
343 DRUG LEVEL ABOVE THERAPEUTIC 91 0.0198
344 SLEEP APNOEA SYNDROME 379 0.0198
345 PANIC ATTACK 723 0.0198
346 GASTROOESOPHAGEAL REFLUX DISEASE 1579 0.0196
347 RED BLOOD CELL SEDIMENTATION RATE INCREASED 217 0.0196
348 FOETAL GROWTH RESTRICTION 119 0.0196
349 HYPERSOMNIA 557 0.0194
350 EUPHORIC MOOD 199 0.0194
351 TREMOR 3224 0.0194
352 STOMATITIS 1177 0.0194
353 VISUAL DISTURBANCE 110 0.0192
354 DISORIENTATION 759 0.0191
355 MATERNAL EXPOSURE BEFORE PREGNANCY 130 0.0190
356 AMMONIA INCREASED 97 0.0190
357 DISSEMINATED INTRAVASCULAR COAGULATION 267 0.0189
358 CARDIO-RESPIRATORY ARREST 790 0.0189
359 HYPERVENTILATION 109 0.0188
360 ULCER HAEMORRHAGE 127 0.0187
361 LOWER RESPIRATORY TRACT INFECTION 852 0.0187
362 RESTLESS LEGS SYNDROME 338 0.0186
363 PRESCRIBED UNDERDOSE 370 0.0185
364 TARDIVE DYSKINESIA 522 0.0185
365 DRY MOUTH 1500 0.0185
366 DELIRIUM 641 0.0185
367 THERAPEUTIC RESPONSE CHANGED 117 0.0184
368 DYSTONIA 355 0.0183
369 MENTAL DISORDER 789 0.0181
370 DERMATITIS BULLOUS 131 0.0181
371 MOTOR DYSFUNCTION 182 0.0178
372 DRUG RESISTANCE 458 0.0178
373 PREMATURE BABY 536 0.0178
374 NECK PAIN 988 0.0177
375 DRUG LEVEL BELOW THERAPEUTIC 97 0.0176
376 RASH PAPULAR 394 0.0176
377 THERAPEUTIC PRODUCT EFFECT DECREASED 787 0.0176
378 WITHDRAWAL SYNDROME 735 0.0175
379 CEREBRAL DISORDER 129 0.0174
380 UNRESPONSIVE TO STIMULI 450 0.0174
381 AUTOIMMUNE DISORDER 169 0.0173
382 IMPAIRED DRIVING ABILITY 197 0.0173
383 VERTIGO 1056 0.0173
384 INCREASED APPETITE 331 0.0173
385 DEPRESSED MOOD 912 0.0172
386 APLASTIC ANAEMIA 90 0.0172
387 ARTHROPATHY 957 0.0172
388 GRANULOCYTOPENIA 98 0.0172
389 NIGHTMARE 593 0.0171
390 HAEMODYNAMIC INSTABILITY 130 0.0170
391 RASH ERYTHEMATOUS 812 0.0170
392 LUNG DISORDER 832 0.0170
393 BRADYKINESIA 100 0.0169
394 EOSINOPHIL COUNT INCREASED 141 0.0169
395 SPEECH DISORDER 884 0.0169
396 LOW BIRTH WEIGHT BABY 134 0.0168
397 INITIAL INSOMNIA 173 0.0168
398 WHEEZING 992 0.0167
399 HEPATOCELLULAR INJURY 237 0.0167
400 SKIN WARM 96 0.0165
401 TRISMUS 85 0.0164
402 TONGUE DISORDER 119 0.0164
403 DIABETIC NEUROPATHY 81 0.0163
404 DRUG DISPENSING ERROR 250 0.0163
405 RASH PUSTULAR 119 0.0163
406 EAR PAIN 316 0.0162
407 DRUG INTOLERANCE 1569 0.0162
408 SCHIZOPHRENIA 197 0.0162
409 GAMMA-GLUTAMYLTRANSFERASE INCREASED 359 0.0162
410 TOXIC ENCEPHALOPATHY 82 0.0162
411 DRUG TOXICITY 220 0.0161
412 ENERGY INCREASED 95 0.0161
413 MUSCULOSKELETAL PAIN 842 0.0161
414 EXTRAPYRAMIDAL DISORDER 397 0.0160
415 SCAB 182 0.0159
416 ILL-DEFINED DISORDER 968 0.0159
417 ANXIETY 4521 0.0159
418 PIGMENTATION DISORDER 98 0.0159
419 INCOHERENT 102 0.0157
420 PHOTOSENSITIVITY REACTION 260 0.0157
421 RESPIRATORY DEPRESSION 192 0.0156
422 MENTAL STATUS CHANGES 435 0.0156
423 LETHARGY 899 0.0156
424 MIOSIS 125 0.0156
425 BLOOD CREATINE PHOSPHOKINASE INCREASED 443 0.0154
426 APPETITE DISORDER 102 0.0154
427 INFUSION RELATED REACTION 1019 0.0154
428 SUDDEN DEATH 162 0.0153
429 BREAST CANCER STAGE II 127 0.0152
430 HEAD INJURY 483 0.0152
431 ANURIA 131 0.0152
432 PNEUMONIA ASPIRATION 380 0.0152
433 SEXUAL DYSFUNCTION 178 0.0152
434 LEUKOCYTOSIS 274 0.0151
435 TREATMENT FAILURE 1251 0.0151
436 RESPIRATORY ARREST 412 0.0149
437 HYPOTHERMIA 151 0.0149
438 POOR QUALITY SLEEP 321 0.0149
439 DYSGRAPHIA 98 0.0149
440 PANIC REACTION 107 0.0148
441 EYE DISCHARGE 154 0.0148
442 URINARY INCONTINENCE 437 0.0147
443 INSOMNIA 3894 0.0146
444 MIDDLE INSOMNIA 272 0.0146
445 WALKING AID USER 96 0.0145
446 WEIGHT INCREASED 3252 0.0145
447 NEUROLOGICAL SYMPTOM 83 0.0145
448 ASPIRATION 158 0.0144
449 TREATMENT NONCOMPLIANCE 789 0.0144
450 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 98 0.0144
451 HALLUCINATION 1085 0.0144
452 FEAR 387 0.0144
453 SWELLING 1333 0.0142
454 MYOCARDITIS 163 0.0142
455 IMPAIRED WORK ABILITY 303 0.0142
456 INTENTIONAL PRODUCT USE ISSUE 1241 0.0142
457 RASH MACULAR 493 0.0141
458 BRAIN INJURY 141 0.0140
459 MENSTRUAL DISORDER 116 0.0140
460 INCONTINENCE 146 0.0138
461 RHABDOMYOLYSIS 576 0.0138
462 JOINT DISLOCATION 146 0.0138
463 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 979 0.0137
464 TRANSAMINASES INCREASED 306 0.0137
465 HYPONATRAEMIA 775 0.0137
466 GENERAL PHYSICAL HEALTH DETERIORATION 1584 0.0137
467 EMOTIONAL DISORDER 422 0.0137
468 ACUTE HEPATIC FAILURE 187 0.0137
469 BODY TEMPERATURE INCREASED 278 0.0136
470 EATING DISORDER 289 0.0136
471 HYPOAESTHESIA 2031 0.0136
472 VISUAL FIELD DEFECT 98 0.0135
473 MOBILITY DECREASED 974 0.0135
474 DISABILITY 268 0.0135
475 AGRANULOCYTOSIS 251 0.0135
476 INJURY 948 0.0135
477 LOSS OF CONSCIOUSNESS 1724 0.0134
478 SKIN LESION 369 0.0134
479 DERMATITIS ALLERGIC 169 0.0134
480 SUBSTANCE ABUSE 109 0.0134
481 BRAIN OEDEMA 169 0.0134
482 ABNORMAL DREAMS 366 0.0132
483 BLOOD LACTATE DEHYDROGENASE INCREASED 210 0.0132
484 NEUTROPHIL COUNT INCREASED 135 0.0132
485 MENINGITIS 88 0.0132
486 OVERDOSE 2830 0.0131
487 PYREXIA 4530 0.0131
488 TACHYCARDIA 1163 0.0131
489 ACIDOSIS 100 0.0131
490 UNINTENDED PREGNANCY 136 0.0130
491 ELECTROCARDIOGRAM ABNORMAL 102 0.0130
492 LOWER LIMB FRACTURE 249 0.0129
493 PREMATURE DELIVERY 206 0.0129
494 IMPAIRED GASTRIC EMPTYING 176 0.0129
495 ECONOMIC PROBLEM 195 0.0129
496 SCIATICA 205 0.0128
497 CONDITION AGGRAVATED 3905 0.0128
498 THERMAL BURN 91 0.0128
499 EYELID OEDEMA 149 0.0128
500 VENTRICULAR FIBRILLATION 142 0.0128
501 INABILITY TO AFFORD MEDICATION 126 0.0127
502 CARDIAC ARREST 1045 0.0126
503 HEPATIC FUNCTION ABNORMAL 472 0.0126
504 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 82 0.0126
505 GALACTORRHOEA 81 0.0126
506 MEDICATION ERROR 699 0.0126
507 WHITE BLOOD CELL COUNT INCREASED 482 0.0126
508 ROAD TRAFFIC ACCIDENT 524 0.0125
509 VITAMIN D DEFICIENCY 122 0.0125
510 CARDIAC MURMUR 108 0.0125
511 RASH PRURITIC 672 0.0124
512 SCAR 212 0.0124
513 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 96 0.0123
514 PHARYNGITIS 153 0.0123
515 DIZZINESS 6143 0.0123
516 DRUG ADMINISTRATION ERROR 377 0.0123
517 PARAESTHESIA 1928 0.0122
518 FORMICATION 85 0.0122
519 PAROSMIA 92 0.0122
520 URINARY RETENTION 405 0.0121
521 ATRIOVENTRICULAR BLOCK COMPLETE 81 0.0121
522 ACUTE RESPIRATORY DISTRESS SYNDROME 214 0.0121
523 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 207 0.0121
524 MUSCULOSKELETAL STIFFNESS 1057 0.0121
525 ALANINE AMINOTRANSFERASE INCREASED 735 0.0120
526 SLUGGISHNESS 122 0.0119
527 LIP SWELLING 398 0.0119
528 HEPATOMEGALY 117 0.0119
529 MUSCULAR WEAKNESS 1343 0.0118
530 ORAL PAIN 263 0.0117
531 TACHYPNOEA 159 0.0117
532 VISION BLURRED 1604 0.0117
533 SWOLLEN TONGUE 364 0.0116
534 URTICARIA 1950 0.0116
535 ACCIDENTAL OVERDOSE 425 0.0116
536 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 102 0.0115
537 CHOLESTASIS 221 0.0115
538 PETECHIAE 120 0.0115
539 BRAIN FOG 180 0.0115
540 INCREASED TENDENCY TO BRUISE 105 0.0114
541 FALL 3790 0.0114
542 FOOT FRACTURE 215 0.0113
543 DRUG ABUSE 936 0.0112
544 GAIT DISTURBANCE 2152 0.0112
545 HYPERLIPIDAEMIA 133 0.0111
546 SKIN DISORDER 371 0.0111
547 ALOPECIA 2182 0.0111
548 HYPOKINESIA 161 0.0111
549 ANOREXIA 142 0.0110
550 MUSCLE TIGHTNESS 178 0.0110
551 DYSPEPSIA 1078 0.0109
552 ASPARTATE AMINOTRANSFERASE INCREASED 580 0.0109
553 LEUKOPENIA 545 0.0109
554 BLOOD SODIUM DECREASED 205 0.0109
555 SINUS BRADYCARDIA 105 0.0109
556 THIRST 193 0.0108
557 PHARYNGEAL OEDEMA 166 0.0108
558 TENDERNESS 112 0.0107
559 THERAPEUTIC RESPONSE UNEXPECTED 481 0.0107
560 ACTIVITIES OF DAILY LIVING IMPAIRED 212 0.0107
561 CENTRAL NERVOUS SYSTEM LESION 147 0.0107
562 THERAPY CHANGE 105 0.0107
563 HYPOALBUMINAEMIA 83 0.0107
564 QUALITY OF LIFE DECREASED 143 0.0106
565 CIRCULATORY COLLAPSE 181 0.0106
566 SHOCK 244 0.0106
567 ATRIOVENTRICULAR BLOCK 82 0.0106
568 HUNGER 147 0.0105
569 CONTUSION 1012 0.0105
570 MOVEMENT DISORDER 337 0.0105
571 DENTAL CARIES 116 0.0105
572 HEPATIC STEATOSIS 195 0.0105
573 DYSPHAGIA 990 0.0104
574 VOMITING 4890 0.0104
575 PRODUCT QUALITY ISSUE 1406 0.0103
576 FEELING JITTERY 197 0.0103
577 FEELING ABNORMAL 2473 0.0103
578 ADVERSE DRUG REACTION 924 0.0103
579 HEPATIC CYTOLYSIS 131 0.0103
580 RETCHING 218 0.0102
581 MULTIPLE ORGAN DYSFUNCTION SYNDROME 289 0.0102
582 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 489 0.0102
583 PARALYSIS 145 0.0101
584 LIVER FUNCTION TEST ABNORMAL 294 0.0101
585 HYPOTHYROIDISM 322 0.0101
586 SKIN REACTION 142 0.0101
587 GASTROINTESTINAL DISORDER 903 0.0101
588 TINNITUS 462 0.0100
589 BEDRIDDEN 132 0.0100
590 PRODUCT USE IN UNAPPROVED INDICATION 2489 0.0100
591 METRORRHAGIA 171 0.0100
592 MUSCLE SPASMS 1836 0.0100
593 BLOOD ALKALINE PHOSPHATASE INCREASED 248 0.0100
594 CYANOSIS 155 0.0098
595 THERAPY NON-RESPONDER 443 0.0098
596 BLOOD TRIGLYCERIDES INCREASED 174 0.0098
597 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 538 0.0098
598 UNDERDOSE 714 0.0098
599 ABDOMINAL DISCOMFORT 1633 0.0097
600 LIVER DISORDER 431 0.0097
601 BRADYCARDIA 514 0.0097
602 OSTEOPENIA 147 0.0097
603 NERVOUSNESS 506 0.0097
604 PANCREATITIS 511 0.0097
605 SENSORY DISTURBANCE 155 0.0096
606 METABOLIC ACIDOSIS 308 0.0096
607 INSURANCE ISSUE 147 0.0096
608 HYPERTENSION 2036 0.0096
609 DISCOMFORT 578 0.0095
610 SWELLING FACE 615 0.0094
611 ABDOMINAL PAIN UPPER 1943 0.0094
612 RIB FRACTURE 194 0.0094
613 RESPIRATORY DISORDER 282 0.0094
614 ATELECTASIS 91 0.0094
615 FACIAL PAIN 84 0.0094
616 OEDEMA 510 0.0094
617 LYMPHOPENIA 133 0.0094
618 PERIPHERAL COLDNESS 129 0.0094
619 SPLENOMEGALY 110 0.0094
620 RHEUMATOID ARTHRITIS 1066 0.0094
621 VENTRICULAR TACHYCARDIA 155 0.0094
622 FOOT DEFORMITY 104 0.0094
623 HEADACHE 5871 0.0094
624 MULTI-ORGAN FAILURE 161 0.0093
625 TEMPERATURE INTOLERANCE 96 0.0093
626 THROAT TIGHTNESS 250 0.0092
627 ANAL INCONTINENCE 83 0.0092
628 ANHEDONIA 242 0.0092
629 HYPERSENSITIVITY 1697 0.0091
630 JOINT SWELLING 1097 0.0091
631 OSTEOPOROSIS 373 0.0091
632 OROPHARYNGEAL PAIN 839 0.0091
633 NERVE COMPRESSION 83 0.0090
634 RESPIRATORY DISTRESS 248 0.0090
635 PRURITUS GENERALISED 193 0.0089
636 ABDOMINAL DISTENSION 931 0.0089
637 HEMIPARESIS 151 0.0089
638 EAR INFECTION 237 0.0089
639 DECREASED ACTIVITY 96 0.0089
640 ANKLE FRACTURE 137 0.0088
641 SKIN EXFOLIATION 745 0.0088
642 CHOKING 171 0.0088
643 HYPOAESTHESIA ORAL 132 0.0087
644 INTENTIONAL DRUG MISUSE 182 0.0087
645 TUBULOINTERSTITIAL NEPHRITIS 163 0.0087
646 HEPATIC FAILURE 262 0.0087
647 DERMATITIS CONTACT 99 0.0087
648 HYPOPHAGIA 221 0.0086
649 TOOTH FRACTURE 95 0.0086
650 JOINT INJURY 183 0.0086
651 PULMONARY FIBROSIS 164 0.0085
652 MUSCLE SPASTICITY 105 0.0085
653 PRODUCT PRESCRIBING ERROR 203 0.0085
654 ADVERSE EVENT 785 0.0085
655 LIGAMENT SPRAIN 84 0.0085
656 DECREASED APPETITE 1972 0.0085
657 PERIPHERAL SWELLING 1305 0.0085
658 PRODUCT ADMINISTRATION ERROR 171 0.0085
659 LOCAL SWELLING 147 0.0084
660 HYPERHIDROSIS 1083 0.0084
661 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 142 0.0084
662 PRODUCT USE ISSUE 1570 0.0083
663 OCULAR HYPERAEMIA 396 0.0083
664 PARAESTHESIA ORAL 120 0.0083
665 MICTURITION URGENCY 95 0.0083
666 DIABETES MELLITUS 633 0.0083
667 NERVOUS SYSTEM DISORDER 259 0.0083
668 VENTRICULAR EXTRASYSTOLES 86 0.0083
669 ERYTHEMA 1702 0.0083
670 NEUROTOXICITY 145 0.0083
671 JAUNDICE 222 0.0082
672 DYSSTASIA 240 0.0082
673 NAUSEA 6504 0.0082
674 PLATELET COUNT INCREASED 107 0.0082
675 HEPATIC CIRRHOSIS 153 0.0081
676 PALLOR 221 0.0081
677 FATIGUE 6307 0.0081
678 ASTHENIA 3045 0.0081
679 UPPER LIMB FRACTURE 161 0.0081
680 ERECTILE DYSFUNCTION 207 0.0081
681 PRURITUS 3092 0.0080
682 DYSURIA 295 0.0080
683 FEEDING DISORDER 162 0.0080
684 FEELING HOT 488 0.0080
685 VISUAL IMPAIRMENT 986 0.0079
686 THERAPY PARTIAL RESPONDER 124 0.0079
687 DRUG INEFFECTIVE 10475 0.0079
688 CARDIOGENIC SHOCK 114 0.0079
689 PRODUCT DISPENSING ERROR 173 0.0079
690 ABASIA 196 0.0079
691 GASTROENTERITIS VIRAL 143 0.0079
692 MENORRHAGIA 155 0.0079
693 INTERVERTEBRAL DISC PROTRUSION 172 0.0079
694 INJECTION SITE REACTION 540 0.0078
695 ORAL DISCOMFORT 109 0.0078
696 COLD SWEAT 137 0.0078
697 VISUAL ACUITY REDUCED 258 0.0078
698 NASOPHARYNGITIS 1430 0.0078
699 DISEASE RECURRENCE 369 0.0077
700 HYPOKALAEMIA 358 0.0077
701 CARPAL TUNNEL SYNDROME 108 0.0077
702 NO THERAPEUTIC RESPONSE 94 0.0077
703 SKIN DISCOLOURATION 354 0.0077
704 WRIST FRACTURE 92 0.0077
705 JOINT STIFFNESS 199 0.0076
706 AMENORRHOEA 133 0.0076
707 PHARYNGITIS STREPTOCOCCAL 82 0.0076
708 THERAPEUTIC RESPONSE DECREASED 459 0.0076
709 HYPOTENSION 1518 0.0076
710 NEPHROLITHIASIS 347 0.0076
711 UPPER RESPIRATORY TRACT INFECTION 348 0.0075
712 INTENTIONAL PRODUCT MISUSE 659 0.0075
713 DRUG WITHDRAWAL SYNDROME NEONATAL 111 0.0075
714 DERMATITIS 157 0.0075
715 DYSMENORRHOEA 99 0.0075
716 ORTHOSTATIC HYPOTENSION 130 0.0075
717 HAEMATOCRIT DECREASED 148 0.0075
718 DIABETES MELLITUS INADEQUATE CONTROL 132 0.0074
719 INFLUENZA LIKE ILLNESS 612 0.0074
720 MALNUTRITION 83 0.0074
721 DEMENTIA 207 0.0074
722 MALAISE 3239 0.0074
723 PHARMACEUTICAL PRODUCT COMPLAINT 191 0.0073
724 WEIGHT DECREASED 2049 0.0073
725 NOCTURIA 89 0.0073
726 SUBDURAL HAEMATOMA 104 0.0073
727 MUSCLE ATROPHY 92 0.0073
728 BACK DISORDER 118 0.0072
729 PRODUCT AVAILABILITY ISSUE 165 0.0072
730 VIRAL INFECTION 241 0.0072
731 ELECTROLYTE IMBALANCE 84 0.0072
732 OFF LABEL USE 6329 0.0072
733 DRUG PRESCRIBING ERROR 138 0.0072
734 HIP ARTHROPLASTY 109 0.0071
735 BURNING SENSATION 499 0.0071
736 OXYGEN SATURATION DECREASED 397 0.0071
737 THROMBOCYTOPENIA 787 0.0070
738 ACCIDENT 84 0.0070
739 IMPAIRED QUALITY OF LIFE 101 0.0070
740 CYST 87 0.0070
741 PANCYTOPENIA 391 0.0070
742 HEAD DISCOMFORT 123 0.0069
743 EYE DISORDER 228 0.0069
744 PANCREATITIS ACUTE 155 0.0069
745 ABNORMAL WEIGHT GAIN 85 0.0069
746 NEURALGIA 167 0.0069
747 ULCER 109 0.0068
748 FREQUENT BOWEL MOVEMENTS 185 0.0068
749 OEDEMA PERIPHERAL 829 0.0068
750 WRONG TECHNIQUE IN DRUG USAGE PROCESS 244 0.0067
751 ABDOMINAL PAIN 1558 0.0067
752 KNEE ARTHROPLASTY 141 0.0067
753 ORAL CANDIDIASIS 88 0.0067
754 PALPITATIONS 780 0.0067
755 URINARY TRACT INFECTION 1136 0.0067
756 SINUSITIS 682 0.0066
757 ACUTE RESPIRATORY FAILURE 128 0.0066
758 LYMPHOCYTE COUNT DECREASED 117 0.0066
759 RED BLOOD CELL COUNT DECREASED 189 0.0066
760 EYE PAIN 372 0.0066
761 THERAPY CESSATION 338 0.0066
762 HAIR TEXTURE ABNORMAL 88 0.0066
763 DRUG WITHDRAWAL SYNDROME 577 0.0066
764 POLLAKIURIA 274 0.0066
765 HEART RATE INCREASED 650 0.0066
766 GENERALISED OEDEMA 81 0.0065
767 EYE SWELLING 243 0.0065
768 BLOOD POTASSIUM DECREASED 196 0.0065
769 ARRHYTHMIA 308 0.0065
770 PRODUCT TASTE ABNORMAL 88 0.0065
771 SYNCOPE 648 0.0065
772 BRONCHITIS 479 0.0065
773 DRY EYE 323 0.0065
774 CANDIDA INFECTION 109 0.0064
775 DRUG DOSE OMISSION 1063 0.0064
776 STAPHYLOCOCCAL INFECTION 212 0.0064
777 CHROMATURIA 145 0.0064
778 SURGERY 376 0.0064
779 CHEST PAIN 1179 0.0064
780 SEASONAL ALLERGY 90 0.0064
781 CHILLS 741 0.0063
782 CONSTIPATION 1374 0.0063
783 PRODUCT PRESCRIBING ISSUE 137 0.0063
784 ECZEMA 329 0.0063
785 INTENTIONAL DOSE OMISSION 179 0.0063
786 WHITE BLOOD CELL COUNT DECREASED 680 0.0063
787 LIMB INJURY 170 0.0063
788 PAIN 3835 0.0062
789 COAGULOPATHY 104 0.0062
790 INCORRECT PRODUCT ADMINISTRATION DURATION 135 0.0062
791 IMMUNE SYSTEM DISORDER 82 0.0062
792 PNEUMONIA 2008 0.0062
793 DEHYDRATION 821 0.0061
794 DYSGEUSIA 457 0.0061
795 BLOOD BILIRUBIN INCREASED 166 0.0061
796 TOOTHACHE 111 0.0061
797 GALLBLADDER DISORDER 109 0.0061
798 ARTHRALGIA 2524 0.0061
799 MYALGIA 1029 0.0060
800 RESPIRATORY FAILURE 439 0.0060
801 NEUTROPHIL COUNT DECREASED 244 0.0060
802 LIMB DISCOMFORT 184 0.0059
803 BLOOD PRESSURE DECREASED 391 0.0059
804 BLINDNESS 239 0.0059
805 FEELING COLD 163 0.0058
806 TOOTH DISORDER 130 0.0058
807 HOSPITALISATION 892 0.0058
808 ACUTE KIDNEY INJURY 888 0.0058
809 HYPOGLYCAEMIA 281 0.0058
810 HYPOXIA 204 0.0058
811 MENSTRUATION IRREGULAR 155 0.0058
812 PERICARDIAL EFFUSION 133 0.0057
813 CHRONIC KIDNEY DISEASE 437 0.0057
814 PRODUCT USE COMPLAINT 90 0.0057
815 CARDIOMYOPATHY 84 0.0057
816 BACTERIAL INFECTION 106 0.0057
817 DRUG EFFECT DECREASED 306 0.0057
818 HYPERTHYROIDISM 82 0.0057
819 KIDNEY INFECTION 111 0.0057
820 HERNIA 109 0.0056
821 PRESYNCOPE 137 0.0056
822 PAIN IN EXTREMITY 1646 0.0056
823 ASTHMA 631 0.0056
824 GASTRITIS 146 0.0055
825 UNEVALUABLE EVENT 418 0.0055
826 IMMUNODEFICIENCY 82 0.0055
827 PRODUCT DOSE OMISSION ISSUE 1615 0.0055
828 HYPERGLYCAEMIA 199 0.0055
829 RESPIRATORY TRACT INFECTION 142 0.0054
830 HAEMATOMA 141 0.0054
831 DIARRHOEA 3484 0.0054
832 THYROID DISORDER 83 0.0054
833 DYSPNOEA 3029 0.0053
834 INTERNATIONAL NORMALISED RATIO INCREASED 152 0.0053
835 SEPTIC SHOCK 231 0.0053
836 DEAFNESS 138 0.0053
837 CELLULITIS 265 0.0053
838 PRODUCT PHYSICAL ISSUE 106 0.0052
839 CYSTITIS 167 0.0052
840 MUSCULOSKELETAL DISCOMFORT 90 0.0052
841 BACK PAIN 1212 0.0052
842 DIABETIC KETOACIDOSIS 125 0.0052
843 DRUG EFFECT INCOMPLETE 188 0.0052
844 PRODUCT DOSE OMISSION 337 0.0052
845 VAGINAL HAEMORRHAGE 223 0.0051
846 HEART RATE IRREGULAR 116 0.0051
847 RENAL FAILURE 681 0.0051
848 SKIN ULCER 131 0.0051
849 PELVIC PAIN 92 0.0051
850 FLUSHING 513 0.0050
851 ABDOMINAL PAIN LOWER 126 0.0050
852 RENAL FAILURE ACUTE 211 0.0050
853 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 353 0.0050
854 BLOOD UREA INCREASED 82 0.0049
855 EMOTIONAL DISTRESS 592 0.0049
856 SEPSIS 545 0.0049
857 TRANSIENT ISCHAEMIC ATTACK 164 0.0049
858 SINUS DISORDER 96 0.0048
859 RHINORRHOEA 313 0.0048
860 ANGIOEDEMA 214 0.0048
861 BLOOD CREATININE INCREASED 315 0.0048
862 CHEST DISCOMFORT 493 0.0048
863 MULTIPLE SCLEROSIS 230 0.0048
864 SPINAL FRACTURE 96 0.0048
865 CHOLELITHIASIS 156 0.0048
866 DYSPHONIA 278 0.0047
867 INTESTINAL OBSTRUCTION 179 0.0047
868 ACNE 360 0.0047
869 SNEEZING 106 0.0047
870 INFLUENZA 526 0.0047
871 INFECTION 680 0.0047
872 RECTAL HAEMORRHAGE 201 0.0047
873 PLATELET COUNT DECREASED 497 0.0047
874 ILLNESS 479 0.0046
875 NEUTROPENIA 628 0.0046
876 LABORATORY TEST ABNORMAL 136 0.0046
877 HOT FLUSH 347 0.0046
878 FRACTURE 87 0.0046
879 MULTIPLE SCLEROSIS RELAPSE 315 0.0046
880 BLOOD PRESSURE INCREASED 700 0.0046
881 BLOOD PRESSURE ABNORMAL 91 0.0046
882 GLAUCOMA 88 0.0046
883 ANAPHYLACTIC REACTION 252 0.0046
884 HYPOCALCAEMIA 86 0.0045
885 RENAL DISORDER 211 0.0045
886 LACRIMATION INCREASED 135 0.0045
887 EYE PRURITUS 150 0.0045
888 SKIN FISSURES 87 0.0044
889 TOOTH LOSS 92 0.0044
890 HEART RATE DECREASED 155 0.0044
891 GASTRIC DISORDER 151 0.0044
892 FUNGAL INFECTION 146 0.0044
893 HAEMATEMESIS 111 0.0044
894 NASAL CONGESTION 257 0.0044
895 NEUROPATHY PERIPHERAL 415 0.0044
896 HIP FRACTURE 140 0.0043
897 AGEUSIA 108 0.0043
898 PAIN IN JAW 122 0.0043
899 COUGH 1200 0.0043
900 POST PROCEDURAL COMPLICATION 82 0.0043
901 ARTHRITIS 335 0.0043
902 FLATULENCE 240 0.0042
903 HEPATOTOXICITY 94 0.0042
904 PULMONARY EMBOLISM 401 0.0042
905 MUCOSAL INFLAMMATION 110 0.0042
906 ORAL HERPES 82 0.0042
907 ANAEMIA 800 0.0042
908 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 846 0.0042
909 PLEURAL EFFUSION 253 0.0042
910 EPISTAXIS 311 0.0042
911 RENAL IMPAIRMENT 349 0.0041
912 BONE MARROW FAILURE 84 0.0041
913 BLOOD PRESSURE FLUCTUATION 98 0.0041
914 CLOSTRIDIUM DIFFICILE INFECTION 89 0.0041
915 INCORRECT DOSE ADMINISTERED 910 0.0040
916 PRODUCT COMPLAINT 100 0.0039
917 EYE IRRITATION 226 0.0039
918 COVID-19 682 0.0039
919 BONE PAIN 227 0.0039
920 THERAPY INTERRUPTED 274 0.0038
921 FAECES DISCOLOURED 83 0.0038
922 CATARACT 225 0.0038
923 FLUID RETENTION 192 0.0038
924 PRODUCT DOSE OMISSION IN ERROR 106 0.0037
925 HAEMOGLOBIN DECREASED 384 0.0037
926 HYPOACUSIS 160 0.0037
927 CEREBRAL HAEMORRHAGE 133 0.0037
928 LOCALISED INFECTION 89 0.0037
929 HAEMATURIA 126 0.0037
930 PAIN OF SKIN 98 0.0036
931 DEEP VEIN THROMBOSIS 234 0.0036
932 PROCEDURAL PAIN 99 0.0036
933 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 183 0.0035
934 RENAL INJURY 104 0.0035
935 EXPIRED PRODUCT ADMINISTERED 114 0.0034
936 PULMONARY OEDEMA 152 0.0034
937 HERPES ZOSTER 194 0.0034
938 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 606 0.0034
939 THROAT IRRITATION 149 0.0033
940 THERAPEUTIC RESPONSE SHORTENED 109 0.0033
941 ANGINA PECTORIS 94 0.0033
942 PRODUCTIVE COUGH 156 0.0033
943 SKIN BURNING SENSATION 234 0.0033
944 PSORIASIS 425 0.0033
945 DERMATITIS ATOPIC 169 0.0032
946 INTERSTITIAL LUNG DISEASE 154 0.0032
947 LACTIC ACIDOSIS 103 0.0032
948 DRY SKIN 423 0.0032
949 DEVICE DISLOCATION 136 0.0031
950 INJECTION SITE MASS 115 0.0031
951 HAEMATOCHEZIA 170 0.0031
952 HAEMORRHAGE 321 0.0031
953 THROMBOSIS 246 0.0031
954 CEREBROVASCULAR ACCIDENT 517 0.0030
955 OSTEONECROSIS 100 0.0030
956 COLITIS 115 0.0030
957 GYNAECOMASTIA 93 0.0030
958 ASCITES 86 0.0029
959 CARDIAC DISORDER 272 0.0029
960 HYPERKALAEMIA 98 0.0028
961 BLOOD GLUCOSE DECREASED 134 0.0028
962 EXTRA DOSE ADMINISTERED 112 0.0028
963 DYSPNOEA EXERTIONAL 104 0.0028
964 BLOOD GLUCOSE INCREASED 498 0.0026
965 DEVICE BREAKAGE 107 0.0026
966 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 87 0.0026
967 NO ADVERSE EVENT 453 0.0025
968 COLITIS ULCERATIVE 110 0.0025
969 ATRIAL FIBRILLATION 233 0.0024
970 CARDIAC FAILURE 186 0.0023
971 DRUG DEPENDENCE 362 0.0022
972 INJECTION SITE BRUISING 176 0.0022
973 INJECTION SITE SWELLING 167 0.0022
974 GASTROINTESTINAL HAEMORRHAGE 182 0.0022
975 MYOCARDIAL INFARCTION 361 0.0021
976 SKIN IRRITATION 94 0.0020
977 INJECTION SITE PAIN 620 0.0020
978 INJECTION SITE PRURITUS 135 0.0020
979 INJECTION SITE ERYTHEMA 242 0.0019
980 DEVICE EXPULSION 125 0.0019
981 DEATH 1607 0.0019
982 DEVICE ISSUE 166 0.0018
983 NEOPLASM MALIGNANT 122 0.0018
984 INJECTION SITE HAEMORRHAGE 139 0.0017
985 ACCIDENTAL EXPOSURE TO PRODUCT 179 0.0017
986 FEBRILE NEUTROPENIA 111 0.0017
987 DEVICE MALFUNCTION 117 0.0017
988 DISEASE PROGRESSION 191 0.0016
989 CARDIAC FAILURE CONGESTIVE 126 0.0016
990 BREAST CANCER 141 0.0015
991 MALIGNANT NEOPLASM PROGRESSION 97 0.0009